ProSomnus

ProSomnus is the first manufacturer to produce oral appliances for the treatment of obstructive sleep apnea, a condition that affects more than 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus' patented devices offer a more comfortable and less invasive alternative to continuous positive airway pressure (CPAP) therapy.